stoxline Quote Chart Rank Option Currency Glossary
  
MAIA Biotechnology, Inc. (MAIA)
4.3399  -0.02 (-0.46%)    05-30 15:13
Open: 4.26
High: 4.4186
Volume: 153,875
  
Pre. Close: 4.36
Low: 4.1807
Market Cap: 95(M)
Technical analysis
2024-05-30 2:45:26 PM
Short term     
Mid term     
Targets 6-month :  5.36 1-year :  6.26
Resists First :  4.59 Second :  5.36
Pivot price 3.49
Supports First :  3.36 Second :  2.6
MAs MA(5) :  4.07 MA(20) :  3.42
MA(100) :  2.11 MA(250) :  1.95
MACD MACD :  0.4 Signal :  0.3
%K %D K(14,3) :  87.6 D(3) :  86.6
RSI RSI(14): 75.5
52-week High :  4.59 Low :  0.81
Price, MAs and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.
[ MAIA ] has closed below upper band by 8.4%. Bollinger Bands are 152.8% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 5 days. This is a sign that the current trend might continue.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 4.6 - 4.62 4.62 - 4.64
Low: 3.98 - 3.99 3.99 - 4.01
Close: 4.33 - 4.36 4.36 - 4.39
Company Description

MAIA Biotechnology, Inc., a clinical stage biotechnology company, engages in the discovery, development, and commercialization of therapies targeting cancer, primarily non-small cell lung cancer. Its lead asset, THIO, is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. The company was founded in 2018 and is headquartered in Chicago, Illinois.

Headline News

Wed, 22 May 2024
MAIA Biotechnology's Unique Telomere Targeting Agent Currently In Clinical Development Shows Promise For The ... - Nasdaq

Tue, 21 May 2024
MAIA Biotechnology (NYSE: MAIA) Makes Strategic Moves - Marketscreener.com

Fri, 17 May 2024
MAIA Biotechnology to Present at the BIO International Convention 2024 - Business Wire

Mon, 29 Apr 2024
MAIA Biotechnology Shares Hit 52-Week High After Director Stock Purchase - MarketWatch

Fri, 05 Apr 2024
MAIA Biotechnology to Present at Two Investor Conferences in April 2024 - Business Wire

Thu, 28 Mar 2024
MAIA Biotechnology Announces Share Purchases by Directors Cristian Luput and Ramiro Guerrero - Yahoo Finance

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Underperform
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Neutral
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Neutral
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Underperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Outperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Underperform
Stock Basics & Statistics
Exchange:
AMEX
Sector:
Healthcare
Industry:
Biotechnology
Shares Out 17 (M)
Shares Float 10 (M)
Held by Insiders 24.3 (%)
Held by Institutions 1.8 (%)
Shares Short 179 (K)
Shares Short P.Month 302 (K)
Stock Financials
EPS -1.45
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 0.2
Profit Margin 0 %
Operating Margin 0 %
Return on Assets (ttm) -103.3 %
Return on Equity (ttm) -243.9 %
Qtrly Rev. Growth 0 %
Gross Profit (p.s.) 0
Sales Per Share 0
EBITDA (p.s.) 0
Qtrly Earnings Growth 0 %
Operating Cash Flow -12 (M)
Levered Free Cash Flow -7 (M)
Stock Valuations
PE Ratio -3.02
PEG Ratio 0
Price to Book value 21.7
Price to Sales 0
Price to Cash Flow -6.36
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android